2010-08-30
Meda has signed an agreement to acquire the US specialty pharmaceutical company Alaven. The acquisition will significantly enhance Meda's marketing capabilities in the US and expand the therapeutic focus to include both gastroenterology and women's health; areas that Meda already operates in ... |
2010-09-02
Swedish biopharmaceutical company BioArctic Neuroscience AB and Japanese pharmaceutical company Eisai Co., Ltd. announce today the start of the first clinical study with BAN2401 in patients with Alzheimer's disease. BAN2401 is an antibody that targets the toxic amyloid aggregates believed to cause ... |
2010-09-28
Welcome to share the launch of a new report on the life science industry in Stockholm-Uppsala. Facts and figures with savvied opinions on potentials and challenges in Sweden’s number one life science region. Read more about BioTech Forum >>> |
|
2010-08-19
It shows in this year's edition of the prestigious Shanghai rank. Three Swedish universities are among the 80 best and all from the Stockholm-Uppsala region.Every year, the Shanghai Jiao Tong University publishes a ranking of the world's best universities – the so-called Shanghai ranking. It is one ... |
2010-07-23
Meda has reached an agreement with the Spanish pharma company Almirall about a respiratory combination project in the Novolizer device that Meda had certain rights to. The project is in research phase, and Almirall has purchased Meda’s rights for 45 million EUR. If questions, please contact: Anders ... |
 Over a three day period you can engage in dozens of pre-arranged partnering meetings with the leading players in Scandinavia's life science industry. BioTech Forum offers you the powerful combination of one-to-one meetings, company presentations, and interesting seminars from different cluster ... |
|